Beyond the Ibuprofen Bottle: What Regular NSAID Use Means for Your Body

By /

Ibuprofen is often the first thing we reach for when pain strikes. For short-term use at the right dose, it can be a reasonable and effective option. But just because it’s available without a prescription doesn’t mean it’s risk-free. For some pain and inflammation sufferers, a short-term fix quietly becomes a long-term habit. This article covers what ibuprofen and other NSAIDs do in the body and who is most at risk. As a naturopath and complementary medicine practitioner, I’m also sharing what the research says about natural alternatives and how naturopathy can support reduced dependence on ibuprofen and other anti-inflammatories.

NSAIDs (non-steroidal anti-inflammatory drugs) include ibuprofen, naproxen, diclofenac and aspirin. They ease pain and inflammation by blocking enzymes that produce prostaglandins. But prostaglandins also protect the gut lining, maintain blood flow to the kidneys and help regulate blood clotting. The same action of NSAIDs that reduces pain is behind many of the side effects.

Ibuprofen is the most commonly used NSAID in Australia, and it’s easy to access. Larger packs are pharmacy-only (Schedule 2), while small packs are sold without scheduling at many supermarkets and even petrol stations.[1] Because it’s so accessible, many people don’t realise it carries regulatory warnings: the TGA notes an increased risk of gastrointestinal bleeding in people with a history of stomach bleeding or ulcers, or with prolonged use.[2]

To be fair, ibuprofen has historically shown the lowest gastrointestinal risk of the common NSAIDs, but this appears to be largely because of the low doses used in practice. At higher doses, its risk is similar to naproxen and indomethacin.[3] Even at usual doses, one large analysis estimated ibuprofen has roughly 2.7 times the risk of upper GI bleeding compared with non-users. Naproxen (an NSAID commonly recommended for period pain) had double the risk compared with ibuprofen (5.6 times).[4]

  • Capsule endoscopy scans show small intestine injury in up to 70-80% of chronic NSAID users, often with no obvious symptoms.[5]
  • Intestinal permeability (aka “leaky gut”) rises within 12 hours of taking an NSAID, and small intestine inflammation follows within 10 days.[6] In long-term NSAID users, it was found that 50-70% had increased intestinal permeability.[6]
  • Up to 25% of chronic users develop upper GI ulcers, and 2-4% experience bleeding or perforation.[6]
  • In long-term users, gut lining damage can manifest as nutrient deficiencies (B12, iron, protein), iron-deficiency anaemia, poor bile-acid absorption, diarrhoea and abdominal pain.[6]
  • The gut microbiota contributes to this damage by crossing through the leaky gut barrier and activating the immune system to create inflammation.[7]
  • When acid-suppressing PPIs (such as Nexium) are prescribed alongside NSAIDs, they can worsen small intestinal injury by promoting the growth of bad bacteria.[5]
  • Bleeding can occur at any time, with or without warning symptoms, though risk is higher in older adults and in people also taking aspirin, corticosteroids, anticoagulants or SSRIs.[8]

NSAIDs reduce blood flow to the kidneys, which matters most when you’re dehydrated or taking certain blood pressure medications. The “triple whammy” combination of an NSAID with a diuretic and an ACE inhibitor or ARB was linked to a 31% higher rate of acute kidney injury, with the risk highest in the first month.[9] Pairing an NSAID with just one of those medications did not show increased risk.[9]

The picture here is dose-dependent. At high doses (2,400 mg/day or more), ibuprofen is associated with a small increase in heart attack and stroke risk, similar to some COX-2 inhibitors. At doses up to 1,200 mg/day, the typical over-the-counter level, no increase has been seen.[10][11] The risk is greater in people with high blood pressure, high cholesterol, diabetes, heart disease or who smoke.[10]

Curcumin: This extract from turmeric root is a great option as an anti-inflammatory with positive effects on gut health. In a trial of 367 people with knee osteoarthritis, turmeric extract (1,500 mg/day) was noninferior to ibuprofen (1,200 mg/day) over four weeks, with significantly less abdominal discomfort.[12] A wider meta-analysis found it less effective than ibuprofen for pain in the short term, but as curcumin acts over the long term, it was still beneficial and more effective than the placebo.[13]

PEA (palmitoylethanolamide): A fatty acid with anti-inflammatory and pain-modulating effects. A 2023 meta-analysis of 11 double-blind trials concluded PEA is effective and well tolerated for chronic pain, though optimal dosing is unclear and must be explored individually under practitioner guidance.[14]

Omega-3 fish oil: Omega-3s are essential nutrients for the body (meaning we can’t make them ourselves). They help to balance and promote anti-inflammatory pathways. One meta-analysis found that 2.7 g/day or more for over three months reduced NSAID use in rheumatoid arthritis.[15] Newer research is more conflicting, sharing variable certainty of effectiveness.[16] Omega-3s are best seen as a supportive, longer-term strategy in reducing long-term use of NSAIDs as part of the bigger picture.

Further options: There are many herbal medicines that support pain and inflammation, such as ginger, corydalis, frankincense, and rosemary. During a naturopathic consult, I can help formulate a specific herbal blend based on your unique needs, along with nutritional and lifestyle support to create a holistic long-term plan to address the root cause or causes of your pain.

No single herb or supplement is a like-for-like replacement for NSAIDs. That isn’t the goal. The bigger concern is how easily short-term use becomes long-term dependence.

It often starts innocently: a flare-up or a sore back, and the tablets relieve it. When the pain returns, NSAIDs are the easiest fix. Over months or years, a “temporary” measure becomes a regular habit. Except no one stops to ask why the pain persists, what else could help, or what it may be costing your gut and overall health. Without a plan, it can be hard to find a chance to stop using NSAIDs, and it can feel daunting when the pain comes back.

That’s where support makes the difference. A structured and holistic approach looks at what’s driving your pain, introduces evidence-based options alongside movement, weight management, sleep and diet, and gradually reduces your reliance on NSAIDs at a pace that’s safe for you.

Before you change anything: don’t stop prescribed medication without advice. Supplements such as high-dose fish oil and curcumin can interact with blood thinners and other medicines. Book a consult and we’ll build a plan that fits you, safely.

Not sure which consult to book? If your pain is minor or manageable, our 20-minute acute naturopathic consult (online), alongside your regular chiropractic care, may be the right fit. If your pain is chronic, a longer initial consult will give us time to explore the whole picture. Or book a discovery call for a free 15-minute chat to see if naturopathy suits your needs.

References

  1. Healthdirect Australia (2026). Advil (ibuprofen) consumer medicine information and scheduling. https://www.healthdirect.gov.au/medicines/brand/snomed/53215011000036102/advil
  2. TGA (9 Sept, 2020). Interim decision in relation to ibuprofen in Notice of interim decisions to amend (or not amend) the current Poisons Standard. Therapeutic Goods Administration, pp. 16-18. https://tga.gov.au/node/286720
  3. Henry D, Lim LL, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT (1996). Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ, 312(7046):1563-6. doi: 10.1136/bmj.312.7046.1563. PMID: 8664664; PMCID: PMC2351326.
  4. Massó González EL, Patrignani P, Tacconelli S, García Rodríguez LA (2010). Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum., 62(6):1592-1601. https://pubmed.ncbi.nlm.nih.gov/20178131/
  5. Piccirelli, S., Barberio, B., Tettoni, E., Treppiccione, C., Pezzuto, E., Tabbone, E., Salvi, D., Bertin, L., Gerardi, V., Cesaro, P., & Savarino, E. V. (2026). Gut Microbiota in NSAID Enteropathy: Current Evidence and Future Perspectives for Therapeutic Strategies. Pharmaceuticals, 19(7), 1045. https://doi.org/10.3390/ph19071045 https://www.mdpi.com/1424-8247/19/7/1045
  6. Prevention and treatment of NSAID-induced small intestine damage. World J Gastroenterol. 2011;17(42):4647. https://wjgnet.com/1007-9327/full/v17/i42/4647.htm
  7. Wang X, Tang Q, Hou H, Zhang W, Li M, Chen D, Gu Y, Wang B, Hou J, Liu Y, Cao H. Gut Microbiota in NSAID Enteropathy: New Insights From Inside. Front Cell Infect Microbiol. 2021 Jul 6;11:679396. doi: 10.3389/fcimb.2021.679396. PMID: 34295835; PMCID: PMC8290187. https://pubmed.ncbi.nlm.nih.gov/34295835/
  8. Viatris (Feb, 2026). Brufen Pain (ibuprofen) tablets: Australian Product Information. https://medsinfo.com.au/api/documents/Brufen_Pain_PI?format=pdf
  9. Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. (2013). Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ, 346:e8525. https://pubmed.ncbi.nlm.nih.gov/23299844/
  10. Medicines and Healthcare products Regulatory Agency. (2015). High-dose ibuprofen (≥2400 mg/day): small increase in cardiovascular risk. MHRA Drug Safety Update. https://www.gov.uk/drug-safety-update/high-dose-ibuprofen-2400mg-day-small-increase-in-cardiovascular-risk
  11. Coxib and traditional NSAID Trialists’ (CNT) Collaboration; Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30. PMID: 23726390; PMCID: PMC3778977. https://pubmed.ncbi.nlm.nih.gov/23726390/
  12. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C, Saengsuwan J, Tantayakom K, Laongpech S. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014 Mar 20;9:451-8. doi: 10.2147/CIA.S58535. PMID: 24672232; PMCID: PMC3964021. https://pubmed.ncbi.nlm.nih.gov/24672232/
  13. Onakpoya IJ, Spencer EA, Perera R, Heneghan CJ. Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials. Int J Rheum Dis. 2017 Apr;20(4):420-433. doi: 10.1111/1756-185X.13069. Epub 2017 May 4. PMID: 28470851. https://pubmed.ncbi.nlm.nih.gov/28470851/
  14. Lang-Illievich K, Klivinyi C, Lasser C, Brenna CTA, Szilagyi IS, Bornemann-Cimenti H. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 2023 Mar 10;15(6):1350. doi: 10.3390/nu15061350. PMID: 36986081; PMCID: PMC10053226. https://pubmed.ncbi.nlm.nih.gov/36986081/
  15. Lee YH, Bae SC, Song GG. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res. 2012 Jul;43(5):356-62. doi: 10.1016/j.arcmed.2012.06.011. Epub 2012 Jul 24. PMID: 22835600. https://pubmed.ncbi.nlm.nih.gov/22835600/
  16. Gkiouras K, Grammatikopoulou MG, Myrogiannis I, Papamitsou T, Rigopoulou EI, Sakkas LI, Bogdanos DP. Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis’ disease activity indicators: a systematic review and meta-analysis of randomized placebo-controlled trials. Crit Rev Food Sci Nutr. 2024;64(1):16-30. doi: 10.1080/10408398.2022.2104210. Epub 2022 Jul 28. PMID: 35900212. https://pubmed.ncbi.nlm.nih.gov/35900212/

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top